Feprazone


Generic Medicine Info
Indications and Dosage
Topical/Cutaneous
Pain and inflammation associated with musculoskeletal and joint disorders
Adult: As 5% cream: Apply as directed.
Contraindications
Previous or active peptic ulceration.
Special Precautions
Allergic disorders, coagulation defects; renal, cardiac or hepatic impairment; history of cardiac failure, left ventricular dysfunction, hypertension, or in patients with oedema due to other reasons; elderly, pregnancy and lactation. Feprazone should be withdrawn if GI lesions develop.
Adverse Reactions
GI disturbances and ulceration; hypersensitivity reactions, CNS effects, tinnitus, photosensitivity, haematuria; blood disorders, fluid retention, raised blood pressure.
Drug Interactions
Antidepressant, SSRIs and venlafaxine may increase risk of bleeding when given with NSAIDs. Risk of side effects increased with concomitant use of aspirin, ciclosporin, ketorolac or other NSAIDs. Lithium and methotrexate may increase risk of toxicity of NSAIDs. Effects of coumarins, phenindione, phenytoin and sulphonylureas are enhanced.
Action
Description:
Mechanism of Action: Feprazone is a phenylbutazone derivative NSAID.
MIMS Class
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Disclaimer: This information is independently developed by MIMS based on Feprazone from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2024 MIMS. All rights reserved. Powered by MIMS.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in